Pfizer Business Finance Contracts & Agreements

74 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to Indenture Dated May 19, 2025 among Pfizer Netherlands International Finance B.V., Pfizer Inc., and The Bank of New York Mellon
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2025
Indenture Agreement among Pfizer Netherlands International Finance B.V., Pfizer Inc., and The Bank of New York Mellon (May 19, 2025)
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2025
Underwriting Agreement for Debt Securities between Pfizer Netherlands International Finance B.V., Pfizer Inc., and Underwriters (May 14, 2025)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2025
Pricing Agreement for Notes Issuance between Pfizer Netherlands International Finance B.V., Pfizer Inc., and Underwriters
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2025
Pfizer Inc. Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2025
Pfizer Inc. Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2024
First Supplemental Indenture to Indenture Dated May 19, 2023 among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc., and The Bank of New York Mellon
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2023
Indenture Agreement among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc., and The Bank of New York Mellon (May 19, 2023)
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2023
Pricing Agreement for Sale of Notes by Pfizer Investment Enterprises Pte. Ltd. (Guaranteed by Pfizer Inc.) to Underwriters
Underwriting Agreements
Pfizer
Pharmaceuticals
2023
Underwriting Agreement for Debt Securities between Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc., and Underwriters (May 16, 2023)
Underwriting Agreements
Pfizer
Pharmaceuticals
2023
Pfizer Acknowledgment and Consent for 2023 Equity Awards (RSUs, TSRUs, PPSs, PSAs)
Equity Distribution Agreements
Pfizer
Pharmaceuticals
NY
2023
Pfizer Inc. Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2023
Pfizer Inc. Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2022
Fifth Supplemental Indenture to Indenture Dated September 7, 2018 for Pfizer Inc. 1.750% Notes Due 2031 (with The Bank of New York Mellon as Trustee)
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2021
Pfizer Inc. $1,000,000,000 1.750% Notes Due 2031 Pricing Agreement with Underwriters
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2021
Pfizer Inc. Debt Securities Underwriting Agreement (August 16, 2021)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2021
Amendment No. 1 to Pfizer 2014 Stock Plan
Stock Agreements
Pfizer
Pharmaceuticals
2021
Amendment No. 1 to Pfizer 2004 Stock Plan (As Amended and Restated)
Stock Agreements
Pfizer
Pharmaceuticals
2021
Description of Pfizer Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2021
Amendment No. 4 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Pfizer
Pharmaceuticals
2021
Amendment No. 3 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Pfizer
Pharmaceuticals
2020
Amendment No. 2 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Pfizer
Pharmaceuticals
UT
2020
Fourth Supplemental Indenture to Indenture Dated September 7, 2018 between Pfizer Inc. and The Bank of New York Mellon, Trustee
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2020
Pfizer Inc. Pricing Agreement for Issuance and Sale of Notes to Underwriters (May 2020)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2020
Pfizer Inc. Debt Securities Underwriting Agreement (May 18, 2020)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2020
Third Supplemental Indenture to Indenture Dated September 7, 2018 for Pfizer Inc. 2.625% Notes Due 2030
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2020
Pfizer Inc. $1,250,000,000 2.625% Notes Due 2030 Pricing Agreement with Underwriters
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2020
Pfizer Inc. Debt Securities Underwriting Agreement (March 25, 2020)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2020
Pfizer Inc. Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Pfizer
Pharmaceuticals
2020
Amendment No. 1 to Separation and Distribution Agreement between Pfizer Inc. and Upjohn Inc.
Modification Agreements
Pfizer
Pharmaceuticals
2020
Second Supplemental Indenture between Pfizer Inc. and The Bank of New York Mellon (March 11, 2019)
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2019
Pfizer Inc. Pricing Agreement for 2022, 2024, 2029, 2039, and 2049 Notes with Underwriters
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2019
Pfizer Inc. Debt Securities Underwriting Agreement (March 4, 2019)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2019
First Supplemental Indenture to Indenture Dated September 7, 2018 between Pfizer Inc. and The Bank of New York Mellon, Trustee
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2018
Pfizer Inc. Indenture Dated September 7, 2018 with The Bank of New York Mellon as Trustee
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2018
Pfizer Inc. Pricing Agreement for Notes Offering with Underwriters (September 2018)
Underwriting Agreements
Pfizer
Pharmaceuticals
NY
2018
Pfizer Inc. Debt Securities Underwriting Agreement with Underwriters (September 4, 2018)
Underwriting Agreements
Pfizer
Pharmaceuticals
2018
Pfizer Form of Acknowledgment and Consent for 2018 Stock Option, RSU, and TSRU Grants
Equity Distribution Agreements
Pfizer
Pharmaceuticals
NY
2018
Tenth Supplemental Indenture to Indenture Dated January 30, 2001 for £1,375,882,000 2.735% Notes due 2043 between Pfizer Inc. and The Bank of New York Mellon
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2017
Eighth Supplemental Indenture to Indenture Dated January 30, 2001 for Pfizer Inc. 4.20% Notes Due 2047 (with The Bank of New York Mellon as Trustee and Paying Agent)
Indenture Agreements
Pfizer
Pharmaceuticals
NY
2017